Additionally, they revealed that the mRNA expression profiles of these cells are associated with better progression-free survival in anti-PD-1-treated patients and a reduction in the tumor size in anti-PD-1/CTLA-4-treated patients [59]. The gene discussed is PDCD1; the disease is neoplasm.